Funding includes $8.4 billion allocated to Project Bioshield, created in 2004, which purchases vaccines for use following an attack involving smallpox, anthrax, and other weaponized pathogens.
Meanwhile, critical resources are being diverted away from public health initiatives designed to protect Americans against natural outbreaks of serious viruses. The result has been failures to fully respond to life-threatening pandemics, such as the 2009 swine flu.
read more